Journal article

Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.

Ralley E Prentice, Doug Tjandra, Mayur Garg, John S Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen

Alimentary Pharmacology and Therapeutics | Published : 2020